Megazol combined with suramin: A chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice

Tropical Medicine and International Health

Volumn 3, Issue 9, 1998, Pages 736-741

  Enanga, B ^a   Keita, M ^a   Chauviere G ^b   Dumas, M ^a   Bouteille, B ^a,c  

^a Inst d'Epidemiol Neurologique N   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

CNS trypanosomiasis; Megazol; Suramin

Indexed keywords

2 AMINO 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOLE; MW 226; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG EFFICACY; FEMALE; HOST PARASITE INTERACTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; TRYPANOSOMA; TRYPANOSOMIASIS;

ANIMALIA; PROTOZOA; TRYPANOSOMA;

EID: 0031658497     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1998.00291.x     Document Type: Article

References (30)

1. Adams JH, Haller L, Boa FY, Doua F, Dago A & Konian K (1986) Human African trypanosomiasis (T. b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive encephalopathy. Neuropathology and Applied Neurobiology 12, 81-94.
2. Berkelhammer G & Asato G (1968) 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl) -1,3,4-thiadiazole. A new antimicrobial agent. Science 162, 11-46.
3. Bertrand J, Ballet J & Sicé A (1935) Les lésions histologiques des centres nerveux dans la trypanosomiase humaine (à propos de deux cas mortels non traités). Annales de l'Institut Pasteur 54, 91-147.
4. Bhagwat SS & Williams M (1997) P-2 purine and pyrimidine receptors: emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors. European Journal of Medicinal Chemistry 32, 183-193.
5. Bouteille B, Marie-Daragon A, Chauvière G, De Albuquerque C, Enanga B, Dardé ML et al. (1995) Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice. Acta Tropica 60, 73-80.
6. Buguer A, Bert J, Tapie Ph, Bogni P, Doua F, Mouanga G et al. (1994) Disturbance of the circadian sleep-wake cycle in Human African Trypanosomiasis. Journal of Sleep Research 3 (Suppl. 1), 35.
7. Burden EJ, Schumacher E & Kelly M (1968) 2-Amino-5-(1-Methyl-5-Nitro-2-Imidazolyl) -1.3.4-thiadiazole, a new antimicrobial agent. VII. Action against subcutaneous Trichomonas vaginalis infections in mice. Antimicrobial Agents and Chemotherapy 7, 538-540.
8. Carpenter MB & Sutin J (1983) Human Neuroanatomy 8th Edn. Williams & Wilkins, Baltimore, USA.
9. Carter NS, Berger BJ & Fairlamb AH (1995) Uptake of diamidine drugs by the P2 nucleoside transporter in melarsan sensitive and resistant Trypanosama brucei brucei. Journal of Biological Chemistry 47, 28153-28157.
10. 2+ responses evoked by ATP and other nucleotides in mammalian brain astrocytes. British Journal of Pharmacology 121, 1700-1706.
11. Collomb H (1957) Encéphalite de la trypanosomiase humaine africaine. Synthèse anatomo-clinique. Gazette Médicale de France Science Médicale Praticque 64, 1069-1078.
12. Enanga B, Labat C, Boudra H, Chauvière G, Keita M, Bouteille B et al. (1997) Simple high-performance liquid chromatographic method to analyse megazol in human and rat plasma. Journal of Chromatography B 696, 261-266.
13. Ferreira RCC & Ferreira LCS (1986) CL 64,855, a potent anti-Trypanosoma cruzi drug, is also mutagenic in Salmonella microsome assay. Memorias Do InstitutO Oswaldo Cruz 81, 49-52.
14. Gallais P & Badier M (1952) Recherche sur l'encéphalite de la trypanosomiase africaine. Corrélations cliniques, anatomiques, électroencéphalographiques, biologiques. Médecine Tropicale 12, 633-675.
15. Jeffrey TE, Sangyeol K, Keshore R, Bidasee KT, Besch HR & Besch JR (1994) Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes. Journal of Pharmacology and Experimental Therapeutics 269, 717-724.
16. Jennings FW (1991) Chemotherapy of CNS- trypanosomiasis: combination chemotherapy with 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin. Tropical Medicine and Parasitology 42, 157-160.
17. Jennings FW, Chauvière G, Viode C & Murray M (1996) Topical chemotherapy for experimental African trypanosomiasis with cerebral involvement: the use of melarsoprol combined with the 5-nitroimidazole, megazol. Tropical Medicine and International Health 1, 363-366.
18. Jennings FW, Urquhart GM, Murray PK & Miller BM (1983) Treatment with suramin and 2-substituted 5-nitroimidazole of chronic murine Trypanosoma brucei infections with central nervous system involvement. Transactions of the Royal Society of Tropical Medicine and Hygiene 77, 693-698.
19. Keita M, Bouteille B, Enanga B, Vallat JM & Dumas M (1997) Trypanosoma brucei brucei: A Long-term Model of Human African Trypanosomiasis in Mice: Meningo-encephalitis, Astrocytosis and Neurological Disorders. Experimental Parasitology 85, 183-192.
20. King BF, Neary JT, Zhu Q, Wang S, Norenberg MD & Burnstock G (1996) P-2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies. Neuroscience 74, 1187-1196.
21. Kuzoe FSA (1993) Current situation of African trypanosomiasis. Acta Tropica 54, 153-162.
22. Molyneux DH (1986). African trypanosomiasis. Clinics in Tropical Medicine and Communicable Diseases 1, 535-555.
23. Moser DR, Cook GA, Ochs DE, Bailey CP, McKane MR & Donelson JE (1989) Detection of Trypanosoma congolense and Trypanosoma brucei subspecies by DNA amplification using the polymerase chain reaction. Parasitology 99, 57-66.
24. Pentreath VW (1995) Trypanosomiasis and the nervous system. Pathology and immunology. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 9-15.
25. Pépin J & Milord F (1991) African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 222-224.
26. Qasabian RA, Schyvens C, Owe-Young R, Killen JP, Macdonald PS, Conigrave AD et al. (1997) Characterization of the P-2 receptors in rabbit pulmonary artery. British Journal of Pharmacology 120, 553-558.
27. Raseroka BH & Ormerod WE (1986) The trypanocidal effect of drugs in different parts of the brain. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 634-641.
28. Turrens JF, Watts JBP, Zhong L & Docampo R (1996) Inhibition of Trypanosoma cruzi and Trypanosoma brucei NADH fumarate reductase by benznidazole and antihelmintic imidazole derivates. Molecular and Biochemical Parasitology 82, 125-129.
29. Van Bogaert L & Janssen P (1957) Contribution à l'étude de la neuropathologie de la trypanosomiase humaine. Annales de La Société Belge de Médecine Tropicale 37, 379-426.
30. Wéry M (1994) Drugs used in the treatment of sleeping sickness (Human African Trypanosomiasis: HAT). International Journal of Antimicrobial Agents 4, 227-238.